mayo clinic glp-1 Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A study offers a potential answer by identifying a distinct biological subtype If you're interested in The
Description
That practical distinction has significant implications for real-world adherence and patient access
27(4): p
its just a normal stage of life, says Judi Chervenak, MD, a reproductive endocrinologist at Montefiore Health System in New York City
Semaglutide is a GLP-1 receptor agonist a class of medication that mimics the incretin hormone GLP-1, which plays a key role in appetite regulation, insulin secretion, and gastric emptying
This approach helps identify individual tolerance thresholds and minimises gastrointestinal side effects
